Aktis Oncology, Inc. AKTS
As ofNov 18, 2026, 10:36 AM EST
- YTD
- -26.40%
- 1 year
- -26.40%
Discussion (169)
Q4 CY20: Deliver design-locked 5.5/6.5 GHz WiFi 6E filter solutions Q4 CY20: Continued ramp with WiFi 6 customer
Q4 CY20: At least 1-2 new design wins in WiFi 6
Q4 CY20: Complete qualification of wafer level packaging for mobile applications Q4 CY20: Complete design of new 5G mobile filters for RF front-end customer
Q4 CY20: Production ramp with tier-1 customer with multiple 5G small cell infrastructure filters Q4 CY20: Design-lock first Massive-MIMO infrastructure filter
Q4 CY20: Receive order for 3.6 GHz CBRS filter solution
Q4 CY20: Begin 1st phase of DARPA program
New presentation update
Q4 CY20: Deliver design-locked 5.5 6.5 GHz WiFi 6E filter solutions Q4 CY20 Continued ramp with WiFi 6 customer
Q4 CY20: At least 1-2 new design wins in WiFi 6
Q4 CY20: Complete qualification of wafer level packaging for mobile applications Q4 CY20: Complete design of new 5G mobile filters for RF front-end customer
Q4 CY20: Production ramp with tier-1 customer with multiple 5G small cell infrastructure filters Q4 CY20: Design-lock first Massive-MIMO infrastructure filter
Q4 CY20: Receive order for 3.6 GHz CBRS filter solution
Q4 CY20: Begin 1st phase of DARPA program
Overall the 10-Q was bullish IMHO.
- $636K in revenues with $0.9 million in backlog for the fiscal year.
- Company estimates that the cash on hand is adequate for next 12 months without tapping ATM
- 33 patents and 73 pending
- Products offer total solutions in UHB
If all current milestones are expected to be met by years end along with new ones that represent substantial revenue potential over next two quarters we should see stock move out of the R&D price range it has been stuck in to new much higher range.
Man they shook that tree hard
Hope you didn’t get shook
Shorts taking advantage with few thousand shares
Get shorty!!!
Nice volume to confirm break out we just need management to deliver Monday
Annual shareholder meeting was this am hopefully management gave the big boys a reason To buy today
Closed at the high nice
